PRIVACY NOTICE Who is Responsible for Your Personal Data In this Privacy Notice, “AstraZeneca’’, ‘’We’’, ‘’Us’’ and ‘’Our’’ refers to the AstraZenecagroup companies. We determine the purposes and manner in which your personal data is collected, used and/or disclosed and mana...
PRIVACY NOTICE Who is Responsible for Your Personal Data In this Privacy Notice, “AstraZeneca’’, ‘’We’’, ‘’Us’’ and ‘’Our’’ refers to the AstraZenecagroup companies. We determine the purposes and manner in which your personal data is collected, used and/or disclosed and mana...
PRIVACY NOTICE Who is Responsible for Your Personal Data In this Privacy Notice, “AstraZeneca’’, ‘’We’’, ‘’Us’’ and ‘’Our’’ refers to the AstraZenecagroup companies. We determine the purposes and manner in which your personal data is collected, used and/or disclosed and mana...
AstraZeneca PLC A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The company sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales...
阿斯利康公司成立于1999年,是一家以创新为核心的全球性制药公司。公司的前身可以追溯到1913年的斯瑞兰斯医药公司(Astra AB)和1923年的瑞典博林格公司(Zeneca Group PLC)。1993年,斯瑞兰斯医药公司与瑞典博林格公司合并,成为阿斯利康公司,总部设在英国伦敦。
阿斯利康的中文名是在该公司于1999年由阿斯特拉公司(Astra AB)和捷利康公司(Zeneca Group PLC)合并后确定的。合并之前,阿斯特拉的中文名是“阿斯特拉”,而捷利康的中文名是“捷利康”。合并后,该公司决定采用一个全新的中文名,既能反映其国际化的背景,又能彰显其在制药行业的领先地位。 中文名的寓意 “阿斯利康”这个...
Deutsche Bank is the depositary bank for AstraZeneca’s ADR programme, which was first established in 1999 following the merger of Astra AB and Zeneca Group PLC. The ADR programme has achieved industry recognition by winning the ‘Best Depositary Receipt Programme’ award from EMEA Finance in 2020...
AstraZeneca Agreement with CSPC Pharmaceutical Group Yesterday, October 7, 2024, AstraZeneca (AZN) announced it entered into an exclusive license agreement with CSPC Pharmaceutical Group Ltd (CSPC) to advance . . . This content is for paid subscribers. Please click here to subscribe or here to ...
The article presents a corporate profile for AstraZeneca PLC, the second largest pharmaceutical company in Great Britain. It notes that AstraZeneca was created through the merger between Astra Pharmaceuticals and Zeneca Group PLC in 1999. A total revenue of 31,601 million dollars has been posted ...
AstraZeneca PLC 肿瘤 呼吸系统疾病 皮肤和肌肉骨骼疾病 小分子化药 单克隆抗体 ADC 疾病领域得分 一眼洞穿机构专注的疾病领域 ss) of CYP-sensitive substrates co-administered with cytokine modulators as reported in the UW DIDB were extracted and examined for each of the CYPs. Co-administration of ...